BELIMUMAB (BENLYSTA) Nursing Considerations

Join NURSING.com to watch the full lesson now.

Included In This Lesson

Outline

What is the Generic Name

BELIMUMAB

What is the Trade Name for BELIMUMAB

BENLYSTA

What is the Indication for BELIMUMAB

  • 1 INDICATIONS AND USAGE BENLYSTA (belimumab) is indicated for the treatment of: ‚Ä¢ patients aged 5 years and older with active, autoantibody ‚Äë positive systemic lupus erythematosus (SLE) who are receiving standard therapy, and ‚Ä¢ adult patients with active lupus nephritis who are receiving standard therapy. Limitations of Use The efficacy of BENLYSTA has not been evaluated in patients with severe active central nervous system lupus. BENLYSTA has not been studied in combination with other biologics. Use of BENLYSTA is not recommended in these situations. BENLYSTA is a B-lymphocyte stimulator (BLyS)-specific inhibitor indicated for the treatment of: ‚Ä¢ patients aged 5 years and older with active, autoantibody-positive systemic lupus erythematosus (SLE) who are receiving standard therapy; ( 1 ) ‚Ä¢ adult patients with active lupus nephritis who are receiving standard therapy. ( 1 ) ‚Ä¢ Limitations of Use: The efficacy of BENLYSTA has not been evaluated in patients with severe active central nervous system lupus. BENLYSTA has not been studied in combination with other biologics. Use of BENLYSTA is not recommended in these situations. ( 1 )

 

 

View Our Nursing Pharmacology Course

 

References: https://open.fda.gov/

 

Other Pharm Resources
Join NURSING.com to watch the full lesson now.
[NextGen]
[NextGen]